SCHEMBL24969443

SCHEMBL24969443

CN(C)CC1CC(S(=O)(=O)Cc2ccccc2)CCC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTR6 P50406 4/20 0.38
CRBN Q96SW2 2/20 0.37
METAP1 P53582 2/20 0.36
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MT-CO2 P00403 1/20 0.34
ALOX5 P09917 1/20 0.34
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
DDB1 Q16531 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP13 P45452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8023959 0.76 ALDH1A1 (0.42) HTR6CRBNMETAP1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL8615141 0.75 ALDH1A1 (0.41) HTR6CRBNMETAP1ALDH1A1KMT2A
SCHEMBL8025758 0.74 METAP1 (0.38) HTR6METAP1
SCHEMBL4665306 0.73 OPRM1 (0.45) HTR6METAP1KMT2A
SCHEMBL24969105 0.73 ALDH1A1 (0.47) HTR6CRBNMETAP1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL8616461 0.73 METAP1 (0.39) METAP1
SCHEMBL24969444 0.73 CRBN (0.43) USP2HPGDHSD17B10CRBNNPC1
SCHEMBL8009453 0.69 SLC6A4 (0.42) HTR6CRBNMETAP1DDB1
Hydrochloric Acid SCHEMBL8614606 0.68 HSP90AA1 (0.41) CRBNMETAP1DDB1
SCHEMBL21234184 0.67 HPGD (0.51) USP2HPGDHSD17B10ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027752-A1 OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF FUDAN UNIVERSITY (CN) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027752-A1 OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF OPRM1, OPRD1, OPRL1 USP2 4488/4885HPGD 1301/4885HSD17B10 2863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.